Grifols Therapeutics LLC

CA · United States · Reporting entity ID 100000005422

Total reported 2019–2025

$16.1M

#370 of 2,960 reporting companies — 0% of all reported industry payments

$28K in general payments across 61 records, plus $16.0M in research funding across 1,679 records.

How it breaks down

General payments $27,907

Research funding $16,025,727

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.